KMT2D基因突变及其共突变基因在弥漫性 大B细胞淋巴瘤患者预后中的意义.Published in:Cancer Research on Prevention & Treatment, 2025, v. 52, n. 2, p. 127, doi. 10.3971/j.issn.1000-8578.2025.24.0557By:木提拜尔·米吉提;漆小龙;热那古力·阿不来提;田文昕;刘沙;马卫媛;王增胜;安利;毛敏;木合拜尔·阿布都尔;李燕Publication type:Article
CDKN2A拷贝数缺失对弥漫性大B细胞 淋巴瘤患者的预后价值.Published in:Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2025, v. 33, n. 2, p. 379, doi. 10.19746/j.cnki.issnl009-2137.2025.02.011By:马卫媛;邵乐天;田文昕;刘沙;李燕Publication type:Article